The largest of these studies (BRCA1 (n = 1,628) and BRCA2 (n = 1,506) mutation carriers) of Pooley et al. [50] found that mutation carriers (regardless of whether cancer-affected or unaffected) have longer telomeres than individuals from the same families without mutations. The gene discussed is BRCA1; the disease is cancer.